DENNIS J. SLAMON, M.D., PH.D. - Corporate Board Profile

BIOMARIN PHARMACEUTICAL INC

Filing Date	Source Excerpt
2016-04-25	Dennis J. Slamon, M.D., Ph.D., joined our Board in March 2014. ... The CGN Committee is composed of four directors, each of whom is “independent” under the listing standards of NASDAQ. The members of the CGN Committee are Dr. Heron (Chair), Mr. Lapalme, Mr. Pyott and Dr. Slamon. ... The Science and Technology Committee is currently composed of five directors: Dr. Lewis (Chair), Mr. Grey, Dr. Heron, Dr. Lawlis and Dr. Slamon. ... Director Compensation in 2015 table shows Dennis J. Slamon's total compensation as $412,820.
2017-04-25	Dennis J. Slamon, M.D., Ph.D., 68, joined our Board in March 2014. Serves on Science and Technology Committee and Corporate Governance and Nominating Committee. 2016 Independent Director Compensation: $367,964.
2018-04-24	Dennis J. Slamon, M.D., Ph.D., 69, March 2014, Professor of Medicine, UCLA Department of Medicine; Director, Clinical/Translational Research at UCLA’s Jonsson Comprehensive Cancer Center; Director, Revlon/UCLA Women’s Cancer Research Program
2019-04-23	Dennis J. Slamon, M.D., Ph.D., 70, March 2014, Professor of Medicine, UCLA Department of Medicine; Director, Clinical/Translational Research at UCLA’s Jonsson Comprehensive Cancer Center; Director, Revlon/UCLA Women’s Cancer Research Program
2020-04-14	Dennis J. Slamon, M.D., Ph.D., joined our Board in March 2014. Dr. Slamon has served as director of Clinical/Translational Research at UCLA’s Jonsson Comprehensive Cancer Center since June 1995 and has served as leader of the Revlon/UCLA Women’s Cancer Research Program at UCLA since its establishment in 1991.
2021-04-13	Dennis J. Slamon, M.D., Ph.D., joined our Board in March 2014. Dr. Slamon has served as director of Clinical/ Translational Research at UCLA’s Jonsson Comprehensive Cancer Center since June 1995 and has served as leader of the Revlon/UCLA Women’s Cancer Research Program at UCLA since its establishment in 1991. The Science and Technology Committee is currently composed of six directors: Dr. Dere (Chair), Mr. Grey, Dr. Heron, Dr. Ho, Dr. Lawlis and Dr. Slamon. 2020 INDEPENDENT DIRECTOR COMPENSATION: Dennis J. Slamon, M.D., Ph.D. Fees Earned ($) 77,188 Stock Awards ($) 458,810 Total ($) 535,998.
2022-04-12	Dennis J. Slamon, M.D., Ph.D., 73, Director Since March 2014, Professor of Medicine, UCLA Department of Medicine; Director, Clinical/Translational Research at UCLA’s Jonsson Comprehensive Cancer Center; Director, Revlon/UCLA Women’s Cancer Research Program. Science and Technology Committee Member. 2021 INDEPENDENT DIRECTOR COMPENSATION: Fees Earned or Paid in Cash $75,000, Stock Awards $397,312, Total $472,312.
2023-04-11	Dennis J. Slamon, M.D., Ph.D. joined our Board in March 2014. Dr. Slamon has served as Director of Clinical/Translational Research at UCLA’s Jonsson Comprehensive Cancer Center since June 1995 and has served as leader of the Revlon/UCLA Women’s Cancer Research Program at UCLA since its establishment in 1991. Since May 1996, Dr. Slamon has been a professor of medicine and Chief of the Division of Hematology/Oncology in the UCLA Department of Medicine. Dr. Slamon also serves as Director of the medical advisory board for the National Colorectal Cancer Research Alliance, a research and fund-raising organization that promotes advances in the treatment of colorectal cancer, and is a member of the boards of Translational Research in Oncology, a global, non-profit, academic clinical research organization, and the National Breast Cancer Coalition, a non-profit organization. Dr. Slamon was awarded the 2019 Lasker-DeBakey Clinical Medical Research Award for the development of a breast cancer drug. A 1970 B.A. honors graduate in biology from Washington & Jefferson College and a 1975 graduate of the University of Chicago Pritzker School of Medicine, Dr. Slamon earned his Ph.D. in cell biology that same year. Dr. Slamon completed his internship and residency at the University of Chicago Hospitals and Clinics, becoming chief resident in 1978. One year later, Dr. Slamon became a fellow in the Division of Hematology/ Oncology at UCLA where he currently serves on the faculty of medicine.